nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—Etoposide—sarcoma	0.19	0.334	CbGbCtD
Nabumetone—PTGS1—Etoposide—sarcoma	0.161	0.282	CbGbCtD
Nabumetone—CYP1A2—Dacarbazine—sarcoma	0.147	0.258	CbGbCtD
Nabumetone—CYP1A2—Etoposide—sarcoma	0.0719	0.126	CbGbCtD
Nabumetone—PTGS2—periosteum—sarcoma	0.00844	0.0876	CbGeAlD
Nabumetone—MPO—endothelium—sarcoma	0.00686	0.0713	CbGeAlD
Nabumetone—PTGS2—leg—sarcoma	0.00673	0.0699	CbGeAlD
Nabumetone—PTGS2—hindlimb—sarcoma	0.00601	0.0624	CbGeAlD
Nabumetone—PTGS2—cartilage tissue—sarcoma	0.00591	0.0614	CbGeAlD
Nabumetone—PTGS2—appendage—sarcoma	0.00515	0.0535	CbGeAlD
Nabumetone—MPO—hematopoietic system—sarcoma	0.00337	0.035	CbGeAlD
Nabumetone—PTGS1—endothelium—sarcoma	0.00325	0.0338	CbGeAlD
Nabumetone—MPO—connective tissue—sarcoma	0.00324	0.0337	CbGeAlD
Nabumetone—PTGS2—endothelium—sarcoma	0.00311	0.0323	CbGeAlD
Nabumetone—MPO—skin of body—sarcoma	0.00293	0.0304	CbGeAlD
Nabumetone—MPO—lymphoid tissue—sarcoma	0.00237	0.0246	CbGeAlD
Nabumetone—MPO—bone marrow—sarcoma	0.00216	0.0224	CbGeAlD
Nabumetone—MPO—testis—sarcoma	0.00185	0.0192	CbGeAlD
Nabumetone—CYP1A2—hematopoietic system—sarcoma	0.00184	0.0192	CbGeAlD
Nabumetone—PTGS2—myometrium—sarcoma	0.00178	0.0185	CbGeAlD
Nabumetone—MPO—liver—sarcoma	0.00175	0.0181	CbGeAlD
Nabumetone—PTGS2—embryo—sarcoma	0.00171	0.0178	CbGeAlD
Nabumetone—PTGS1—seminal vesicle—sarcoma	0.00168	0.0175	CbGeAlD
Nabumetone—PTGS2—seminal vesicle—sarcoma	0.00161	0.0167	CbGeAlD
Nabumetone—PTGS1—hematopoietic system—sarcoma	0.0016	0.0166	CbGeAlD
Nabumetone—PTGS1—connective tissue—sarcoma	0.00154	0.016	CbGeAlD
Nabumetone—PTGS2—hematopoietic system—sarcoma	0.00153	0.0159	CbGeAlD
Nabumetone—PTGS2—connective tissue—sarcoma	0.00147	0.0153	CbGeAlD
Nabumetone—PTGS1—smooth muscle tissue—sarcoma	0.00141	0.0146	CbGeAlD
Nabumetone—PTGS1—skin of body—sarcoma	0.00139	0.0144	CbGeAlD
Nabumetone—PTGS2—smooth muscle tissue—sarcoma	0.00135	0.014	CbGeAlD
Nabumetone—MPO—lymph node—sarcoma	0.00134	0.0139	CbGeAlD
Nabumetone—PTGS2—skin of body—sarcoma	0.00133	0.0138	CbGeAlD
Nabumetone—PTGS1—cardiac atrium—sarcoma	0.00121	0.0126	CbGeAlD
Nabumetone—PTGS1—uterus—sarcoma	0.00121	0.0125	CbGeAlD
Nabumetone—PTGS2—uterus—sarcoma	0.00115	0.012	CbGeAlD
Nabumetone—PTGS2—lymphoid tissue—sarcoma	0.00108	0.0112	CbGeAlD
Nabumetone—PTGS1—tendon—sarcoma	0.00106	0.011	CbGeAlD
Nabumetone—PTGS2—tendon—sarcoma	0.00101	0.0105	CbGeAlD
Nabumetone—PTGS2—bone marrow—sarcoma	0.000979	0.0102	CbGeAlD
Nabumetone—CYP1A2—liver—sarcoma	0.000956	0.00992	CbGeAlD
Nabumetone—PTGS1—testis—sarcoma	0.000876	0.0091	CbGeAlD
Nabumetone—PTGS2—liver—sarcoma	0.000791	0.00822	CbGeAlD
Nabumetone—Feeling abnormal—Dactinomycin—sarcoma	0.000705	0.00211	CcSEcCtD
Nabumetone—Gastrointestinal pain—Thiotepa—sarcoma	0.000705	0.00211	CcSEcCtD
Nabumetone—Ill-defined disorder—Etoposide—sarcoma	0.000704	0.00211	CcSEcCtD
Nabumetone—Anaemia—Etoposide—sarcoma	0.000701	0.0021	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dactinomycin—sarcoma	0.0007	0.0021	CcSEcCtD
Nabumetone—Increased appetite—Doxorubicin—sarcoma	0.000696	0.00209	CcSEcCtD
Nabumetone—Insomnia—Vincristine—sarcoma	0.000691	0.00207	CcSEcCtD
Nabumetone—Paraesthesia—Vincristine—sarcoma	0.000686	0.00206	CcSEcCtD
Nabumetone—Urticaria—Thiotepa—sarcoma	0.000685	0.00205	CcSEcCtD
Nabumetone—Malaise—Etoposide—sarcoma	0.000684	0.00205	CcSEcCtD
Nabumetone—Dermatitis bullous—Doxorubicin—sarcoma	0.000684	0.00205	CcSEcCtD
Nabumetone—Vertigo—Etoposide—sarcoma	0.000682	0.00204	CcSEcCtD
Nabumetone—Body temperature increased—Thiotepa—sarcoma	0.000682	0.00204	CcSEcCtD
Nabumetone—Abdominal pain—Thiotepa—sarcoma	0.000682	0.00204	CcSEcCtD
Nabumetone—Leukopenia—Etoposide—sarcoma	0.000679	0.00204	CcSEcCtD
Nabumetone—Abdominal pain—Dactinomycin—sarcoma	0.000676	0.00203	CcSEcCtD
Nabumetone—Body temperature increased—Dactinomycin—sarcoma	0.000676	0.00203	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000675	0.00202	CcSEcCtD
Nabumetone—Paraesthesia—Mitoxantrone—sarcoma	0.000669	0.002	CcSEcCtD
Nabumetone—Loss of consciousness—Etoposide—sarcoma	0.000667	0.002	CcSEcCtD
Nabumetone—Decreased appetite—Vincristine—sarcoma	0.000665	0.00199	CcSEcCtD
Nabumetone—Dyspnoea—Mitoxantrone—sarcoma	0.000664	0.00199	CcSEcCtD
Nabumetone—Cough—Etoposide—sarcoma	0.000662	0.00198	CcSEcCtD
Nabumetone—Somnolence—Mitoxantrone—sarcoma	0.000662	0.00198	CcSEcCtD
Nabumetone—Fatigue—Vincristine—sarcoma	0.000659	0.00198	CcSEcCtD
Nabumetone—Dyspepsia—Mitoxantrone—sarcoma	0.000655	0.00196	CcSEcCtD
Nabumetone—Hypertension—Etoposide—sarcoma	0.000655	0.00196	CcSEcCtD
Nabumetone—Constipation—Vincristine—sarcoma	0.000654	0.00196	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000654	0.00196	CcSEcCtD
Nabumetone—Liver function test abnormal—Epirubicin—sarcoma	0.000652	0.00195	CcSEcCtD
Nabumetone—Decreased appetite—Mitoxantrone—sarcoma	0.000647	0.00194	CcSEcCtD
Nabumetone—Hypokalaemia—Epirubicin—sarcoma	0.000643	0.00193	CcSEcCtD
Nabumetone—Fatigue—Mitoxantrone—sarcoma	0.000642	0.00192	CcSEcCtD
Nabumetone—Discomfort—Etoposide—sarcoma	0.000638	0.00191	CcSEcCtD
Nabumetone—Constipation—Mitoxantrone—sarcoma	0.000637	0.00191	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000636	0.00191	CcSEcCtD
Nabumetone—Hypersensitivity—Thiotepa—sarcoma	0.000635	0.0019	CcSEcCtD
Nabumetone—PTGS1—lymph node—sarcoma	0.000635	0.00659	CbGeAlD
Nabumetone—Hypersensitivity—Dactinomycin—sarcoma	0.00063	0.00189	CcSEcCtD
Nabumetone—Gastrointestinal pain—Vincristine—sarcoma	0.000625	0.00187	CcSEcCtD
Nabumetone—Gastritis—Epirubicin—sarcoma	0.000625	0.00187	CcSEcCtD
Nabumetone—Confusional state—Etoposide—sarcoma	0.000624	0.00187	CcSEcCtD
Nabumetone—Anaphylactic shock—Etoposide—sarcoma	0.000619	0.00186	CcSEcCtD
Nabumetone—Asthenia—Thiotepa—sarcoma	0.000619	0.00185	CcSEcCtD
Nabumetone—Asthenia—Dactinomycin—sarcoma	0.000614	0.00184	CcSEcCtD
Nabumetone—Feeling abnormal—Mitoxantrone—sarcoma	0.000614	0.00184	CcSEcCtD
Nabumetone—Asthma—Epirubicin—sarcoma	0.00061	0.00183	CcSEcCtD
Nabumetone—Dysphagia—Epirubicin—sarcoma	0.00061	0.00183	CcSEcCtD
Nabumetone—Pruritus—Thiotepa—sarcoma	0.00061	0.00183	CcSEcCtD
Nabumetone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000609	0.00182	CcSEcCtD
Nabumetone—PTGS2—lymph node—sarcoma	0.000607	0.0063	CbGeAlD
Nabumetone—Thrombocytopenia—Etoposide—sarcoma	0.000606	0.00182	CcSEcCtD
Nabumetone—Abdominal pain—Vincristine—sarcoma	0.000604	0.00181	CcSEcCtD
Nabumetone—Body temperature increased—Vincristine—sarcoma	0.000604	0.00181	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—sarcoma	0.000603	0.00181	CcSEcCtD
Nabumetone—Hyperhidrosis—Etoposide—sarcoma	0.000599	0.00179	CcSEcCtD
Nabumetone—Pancreatitis—Epirubicin—sarcoma	0.000598	0.00179	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—sarcoma	0.000595	0.00178	CcSEcCtD
Nabumetone—Angina pectoris—Epirubicin—sarcoma	0.000595	0.00178	CcSEcCtD
Nabumetone—Urticaria—Mitoxantrone—sarcoma	0.000591	0.00177	CcSEcCtD
Nabumetone—Anorexia—Etoposide—sarcoma	0.00059	0.00177	CcSEcCtD
Nabumetone—Diarrhoea—Thiotepa—sarcoma	0.00059	0.00177	CcSEcCtD
Nabumetone—Abdominal pain—Mitoxantrone—sarcoma	0.000589	0.00176	CcSEcCtD
Nabumetone—Body temperature increased—Mitoxantrone—sarcoma	0.000589	0.00176	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000588	0.00176	CcSEcCtD
Nabumetone—Diarrhoea—Dactinomycin—sarcoma	0.000585	0.00175	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—sarcoma	0.000578	0.00173	CcSEcCtD
Nabumetone—Dysuria—Epirubicin—sarcoma	0.000571	0.00171	CcSEcCtD
Nabumetone—Dizziness—Thiotepa—sarcoma	0.00057	0.00171	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—sarcoma	0.000565	0.00169	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—sarcoma	0.000565	0.00169	CcSEcCtD
Nabumetone—Hypersensitivity—Vincristine—sarcoma	0.000563	0.00169	CcSEcCtD
Nabumetone—Photosensitivity reaction—Epirubicin—sarcoma	0.000557	0.00167	CcSEcCtD
Nabumetone—Paraesthesia—Etoposide—sarcoma	0.000556	0.00167	CcSEcCtD
Nabumetone—Weight increased—Epirubicin—sarcoma	0.000556	0.00167	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—sarcoma	0.000554	0.00166	CcSEcCtD
Nabumetone—Weight decreased—Epirubicin—sarcoma	0.000552	0.00166	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—sarcoma	0.000552	0.00165	CcSEcCtD
Nabumetone—Hyperglycaemia—Epirubicin—sarcoma	0.000551	0.00165	CcSEcCtD
Nabumetone—Somnolence—Etoposide—sarcoma	0.000551	0.00165	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—sarcoma	0.00055	0.00165	CcSEcCtD
Nabumetone—Hypersensitivity—Mitoxantrone—sarcoma	0.000549	0.00164	CcSEcCtD
Nabumetone—Asthenia—Vincristine—sarcoma	0.000548	0.00164	CcSEcCtD
Nabumetone—Vomiting—Thiotepa—sarcoma	0.000548	0.00164	CcSEcCtD
Nabumetone—Pneumonia—Epirubicin—sarcoma	0.000547	0.00164	CcSEcCtD
Nabumetone—Vomiting—Dactinomycin—sarcoma	0.000544	0.00163	CcSEcCtD
Nabumetone—Rash—Thiotepa—sarcoma	0.000544	0.00163	CcSEcCtD
Nabumetone—Dermatitis—Thiotepa—sarcoma	0.000543	0.00163	CcSEcCtD
Nabumetone—Headache—Thiotepa—sarcoma	0.00054	0.00162	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00054	0.00162	CcSEcCtD
Nabumetone—Rash—Dactinomycin—sarcoma	0.000539	0.00162	CcSEcCtD
Nabumetone—Decreased appetite—Etoposide—sarcoma	0.000538	0.00161	CcSEcCtD
Nabumetone—Renal failure—Epirubicin—sarcoma	0.000535	0.0016	CcSEcCtD
Nabumetone—Asthenia—Mitoxantrone—sarcoma	0.000534	0.0016	CcSEcCtD
Nabumetone—Fatigue—Etoposide—sarcoma	0.000534	0.0016	CcSEcCtD
Nabumetone—Stomatitis—Epirubicin—sarcoma	0.000531	0.00159	CcSEcCtD
Nabumetone—Jaundice—Epirubicin—sarcoma	0.000531	0.00159	CcSEcCtD
Nabumetone—Constipation—Etoposide—sarcoma	0.00053	0.00159	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—sarcoma	0.000528	0.00158	CcSEcCtD
Nabumetone—Diarrhoea—Vincristine—sarcoma	0.000523	0.00157	CcSEcCtD
Nabumetone—Haematuria—Epirubicin—sarcoma	0.000519	0.00156	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—sarcoma	0.000516	0.00155	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—sarcoma	0.000514	0.00154	CcSEcCtD
Nabumetone—Nausea—Thiotepa—sarcoma	0.000512	0.00154	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—sarcoma	0.000511	0.00153	CcSEcCtD
Nabumetone—Feeling abnormal—Etoposide—sarcoma	0.00051	0.00153	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—sarcoma	0.000509	0.00153	CcSEcCtD
Nabumetone—Diarrhoea—Mitoxantrone—sarcoma	0.000509	0.00153	CcSEcCtD
Nabumetone—Nausea—Dactinomycin—sarcoma	0.000508	0.00152	CcSEcCtD
Nabumetone—Agranulocytosis—Epirubicin—sarcoma	0.000508	0.00152	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—sarcoma	0.000507	0.00152	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—sarcoma	0.000506	0.00152	CcSEcCtD
Nabumetone—Dizziness—Vincristine—sarcoma	0.000506	0.00152	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000499	0.0015	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—sarcoma	0.000495	0.00148	CcSEcCtD
Nabumetone—Urticaria—Etoposide—sarcoma	0.000492	0.00147	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—sarcoma	0.000491	0.00147	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—sarcoma	0.000491	0.00147	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—sarcoma	0.000491	0.00147	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—sarcoma	0.00049	0.00147	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—sarcoma	0.00049	0.00147	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—sarcoma	0.000489	0.00146	CcSEcCtD
Nabumetone—Vomiting—Vincristine—sarcoma	0.000486	0.00146	CcSEcCtD
Nabumetone—Rash—Vincristine—sarcoma	0.000482	0.00144	CcSEcCtD
Nabumetone—Dermatitis—Vincristine—sarcoma	0.000482	0.00144	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—sarcoma	0.00048	0.00144	CcSEcCtD
Nabumetone—Headache—Vincristine—sarcoma	0.000479	0.00144	CcSEcCtD
Nabumetone—Vomiting—Mitoxantrone—sarcoma	0.000473	0.00142	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—sarcoma	0.000471	0.00141	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—sarcoma	0.00047	0.00141	CcSEcCtD
Nabumetone—Rash—Mitoxantrone—sarcoma	0.000469	0.00141	CcSEcCtD
Nabumetone—Dermatitis—Mitoxantrone—sarcoma	0.000469	0.00141	CcSEcCtD
Nabumetone—Headache—Mitoxantrone—sarcoma	0.000466	0.0014	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—sarcoma	0.000462	0.00138	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—sarcoma	0.000456	0.00137	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—sarcoma	0.000456	0.00137	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—sarcoma	0.000454	0.00136	CcSEcCtD
Nabumetone—Nausea—Vincristine—sarcoma	0.000454	0.00136	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—sarcoma	0.000452	0.00136	CcSEcCtD
Nabumetone—Asthenia—Etoposide—sarcoma	0.000444	0.00133	CcSEcCtD
Nabumetone—Nausea—Mitoxantrone—sarcoma	0.000442	0.00133	CcSEcCtD
Nabumetone—Chills—Epirubicin—sarcoma	0.000438	0.00131	CcSEcCtD
Nabumetone—Pruritus—Etoposide—sarcoma	0.000438	0.00131	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—sarcoma	0.000436	0.00131	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—sarcoma	0.000436	0.00131	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—sarcoma	0.000432	0.00129	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—sarcoma	0.000427	0.00128	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—sarcoma	0.000424	0.00127	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—sarcoma	0.000422	0.00126	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—sarcoma	0.000419	0.00126	CcSEcCtD
Nabumetone—Tension—Epirubicin—sarcoma	0.000417	0.00125	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—sarcoma	0.000413	0.00124	CcSEcCtD
Nabumetone—Dizziness—Etoposide—sarcoma	0.00041	0.00123	CcSEcCtD
Nabumetone—Chills—Doxorubicin—sarcoma	0.000406	0.00122	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—sarcoma	0.000404	0.00121	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—sarcoma	0.000399	0.0012	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—sarcoma	0.000395	0.00118	CcSEcCtD
Nabumetone—Vomiting—Etoposide—sarcoma	0.000394	0.00118	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—sarcoma	0.000393	0.00118	CcSEcCtD
Nabumetone—Agitation—Epirubicin—sarcoma	0.000391	0.00117	CcSEcCtD
Nabumetone—Rash—Etoposide—sarcoma	0.00039	0.00117	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—sarcoma	0.00039	0.00117	CcSEcCtD
Nabumetone—Headache—Etoposide—sarcoma	0.000388	0.00116	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—sarcoma	0.000388	0.00116	CcSEcCtD
Nabumetone—Tension—Doxorubicin—sarcoma	0.000386	0.00116	CcSEcCtD
Nabumetone—Malaise—Epirubicin—sarcoma	0.000384	0.00115	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—sarcoma	0.000382	0.00115	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—sarcoma	0.000382	0.00115	CcSEcCtD
Nabumetone—Syncope—Epirubicin—sarcoma	0.000381	0.00114	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—sarcoma	0.000381	0.00114	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—sarcoma	0.000376	0.00113	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—sarcoma	0.000374	0.00112	CcSEcCtD
Nabumetone—Cough—Epirubicin—sarcoma	0.000371	0.00111	CcSEcCtD
Nabumetone—Nausea—Etoposide—sarcoma	0.000368	0.0011	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—sarcoma	0.000367	0.0011	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—sarcoma	0.000365	0.00109	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—sarcoma	0.000364	0.00109	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—sarcoma	0.000362	0.00108	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—sarcoma	0.000361	0.00108	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—sarcoma	0.000358	0.00107	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—sarcoma	0.000355	0.00106	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—sarcoma	0.000354	0.00106	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—sarcoma	0.000354	0.00106	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—sarcoma	0.000353	0.00106	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—sarcoma	0.000352	0.00106	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—sarcoma	0.00035	0.00105	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—sarcoma	0.000348	0.00104	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—sarcoma	0.000347	0.00104	CcSEcCtD
Nabumetone—Oedema—Epirubicin—sarcoma	0.000347	0.00104	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—sarcoma	0.000346	0.00104	CcSEcCtD
Nabumetone—Cough—Doxorubicin—sarcoma	0.000343	0.00103	CcSEcCtD
Nabumetone—Shock—Epirubicin—sarcoma	0.000342	0.00102	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—sarcoma	0.00034	0.00102	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—sarcoma	0.00034	0.00102	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—sarcoma	0.000336	0.00101	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—sarcoma	0.000334	0.001	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—sarcoma	0.000331	0.000992	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—sarcoma	0.000331	0.000992	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—sarcoma	0.000328	0.000982	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—sarcoma	0.000324	0.000971	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—sarcoma	0.000321	0.000963	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—sarcoma	0.000321	0.000963	CcSEcCtD
Nabumetone—Shock—Doxorubicin—sarcoma	0.000316	0.000947	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—sarcoma	0.000314	0.000943	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—sarcoma	0.000314	0.000941	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—sarcoma	0.000312	0.000934	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—sarcoma	0.000311	0.000931	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—sarcoma	0.000309	0.000928	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—sarcoma	0.000309	0.000925	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—sarcoma	0.000306	0.000918	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—sarcoma	0.000306	0.000916	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—sarcoma	0.000302	0.000905	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—sarcoma	0.000299	0.000897	CcSEcCtD
Nabumetone—Constipation—Epirubicin—sarcoma	0.000297	0.00089	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—sarcoma	0.000291	0.000871	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—sarcoma	0.000288	0.000865	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—sarcoma	0.000286	0.000858	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—sarcoma	0.000286	0.000857	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—sarcoma	0.000286	0.000856	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—sarcoma	0.000284	0.000851	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—sarcoma	0.000283	0.000848	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—sarcoma	0.000279	0.000837	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—sarcoma	0.000277	0.00083	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—sarcoma	0.000276	0.000827	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—sarcoma	0.000275	0.000823	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—sarcoma	0.000274	0.000823	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—sarcoma	0.000274	0.000823	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—sarcoma	0.000265	0.000793	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000263	0.000787	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—sarcoma	0.000256	0.000767	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—sarcoma	0.000255	0.000765	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—sarcoma	0.000254	0.000761	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—sarcoma	0.000254	0.000761	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—sarcoma	0.000249	0.000747	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—sarcoma	0.000246	0.000736	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—sarcoma	0.000238	0.000712	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—sarcoma	0.000237	0.000709	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—sarcoma	0.00023	0.000691	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—sarcoma	0.00023	0.000688	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—sarcoma	0.000227	0.000681	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—sarcoma	0.000221	0.000662	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—sarcoma	0.00022	0.000659	CcSEcCtD
Nabumetone—Rash—Epirubicin—sarcoma	0.000219	0.000656	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—sarcoma	0.000219	0.000655	CcSEcCtD
Nabumetone—Headache—Epirubicin—sarcoma	0.000217	0.000652	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—sarcoma	0.000212	0.000637	CcSEcCtD
Nabumetone—Nausea—Epirubicin—sarcoma	0.000206	0.000618	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—sarcoma	0.000204	0.000612	CcSEcCtD
Nabumetone—Rash—Doxorubicin—sarcoma	0.000203	0.000607	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—sarcoma	0.000202	0.000607	CcSEcCtD
Nabumetone—Headache—Doxorubicin—sarcoma	0.000201	0.000603	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—sarcoma	0.000191	0.000572	CcSEcCtD
